17 June 2010, Singapore. Singapore’s largest multi-purpose international business event venue willwelcome for the first time two back-to-back bioscience conferences this month. From 22 to 25 June, the
Third Annual World Cancer Congress 2010 (WCC 2010) will see more than 3,000 academics, clinical and
medical researchers, oncologists and drug manufacturers gathering to discuss the latest research findings in
oncology at 125 sessions in Singapore Expo’s Conference Halls. Presentations and speeches will also be
delivered by keynote speakers hailing from the leading institutions and research facilities around the world.
An exhibition will be held concurrently at Halls 2 and 3 and diversified social hours, such as on-site coffee
breaks and corporation seminars have been set aside within the scientific programme to make the exhibition
more interactive. Registration starts on Monday, 21 June, from 9.00am to 9.00pm.
Set to take place right after WCC 2010 is NeuroTalk 2010 (25 to 28 June), which will be a sustainable
platform for exchanging up-to-the-minute upstream and downstream achievements, industrial needs and
research opportunities within of the neuroscience field in Asia Pacific. Over 1,000 delegates will have the
chance to interact with academics and researchers from renowned medical institutions such as Albert
Einstein College of Medicine, Harvard Medical School and National Academy of Sciences (USA), Osaka
University (Japan), and Prince of Wales Medical Research Institute (Australia).
Singapore the top destination for biomedical sciences professionals
The sustained growth of Asia’s biomedical sciences industry is in stark contrast to the consolidation and even
downsizing of pharmaceutical companies in Europe and the US, and Singapore is blazing the trail with over
thirty renowned international bioscience companies and research institutes, including Abbott, Bayer and
GlaxoSmithKline1, anchoring their Asia Pacific headquarters here. Additionally, bio-pharmaceutical
professionals in the region view Singapore as the Asian city with the strongest bioscience industry and the
best career prospects, according to a survey conducted by RSA Singapore2, a global life sciences executive
recruitment agency.
As Singapore establishes its own Cancer Research Centre of Excellence (headed by Prof Daniel Tenen of
Harvard Medical School3) and the region’s first integrated neuroscience centre4, it comes as no surprise that
Expo is now playing host to WCC 2010 and NeuroTalk 2010. With an impressive track record in housing
corporate and trade conferences and meetings organised by leading agencies and organisations in the
defence, financial and technology sectors, Expo is well-positioned to extend the same service excellence to
the burgeoning Asian biomedical community.
Says Mr Chandran Nair, Deputy General Manager of Singex Venues Pte Ltd, the managing company of
Expo, “While some have embraced technology and adopted video and web conferencing, most have
remained strong believers in knowledge-sharing and networking at fraternity and industry events. With
Singapore poised to maintain her position as the global powerhouse for medical professionals, I am
confident that more opportunities for Singapore Expo to offer our venue’s facilities and services to even more
bioscience and pharmaceutical organizations looking to meet in Singapore.”
